Abstract
The endogenous substance lysophosphatidic acid (LPA) has been found to generate proliferation of cultured smooth muscle cells (SMC). Therefore, the effect of LPA on human benign prostate hyperplasia (BPH) could be of interest. The proliferative effect of LPA on cultured human prostatic SMC from specimens obtained at trans-urethral resection of the prostate (TURP) because of BPH, was analyzed by [3H]-thymidine and [35S]-methionine incorporation. In addition, LPA stimulated BPH SMC were treated with papaverin, forskolin, sildenafil or zaprinast, well known to increase the intracellular level of cAMP or cGMP. LPA produced a dose-dependent increase in BPH SMC, both regarding DNA- and protein-synthesis with EC50 values of 3 and 10 microM, respectively. Furthermore, both papaverin, a general phosphodiesterase inhibitor regarding cAMP hydrolyzes, and forskolin, an adenylyl cyclase stimulating agent, inhibited the LPA-stimulated DNA replication in a dose dependent manner with IC50 = 2.5, and 0.35 microM, respectively. cGMP increasing agents, such as the NO-donors SIN-1 and SNAP, produced a weak anti-proliferative response. However, both phosphodiesterase 5 inhibitors sildenafil (Viagra) and zaprinast efficiently blocked DNA replication...Continue Reading
References
Nov 1, 1992·British Journal of Pharmacology·T TsujiiH Oshima
Apr 1, 1988·The Journal of Urology·J E FowlerA Mounzer
Jan 1, 1989·The Prostate. Supplement·J T Isaacs, D S Coffey
Oct 6, 1989·Cell·E J van CorvenW H Moolenaar
Dec 1, 1986·The Journal of Cell Biology·O SkalliG Gabbiani
Jan 1, 1994·The Journal of Urology·E T Goluboff, C A Olsson
Nov 26, 1994·Lancet·E J LangfordS Moncada
Jun 16, 1995·Biochemical Pharmacology·P R TomlinsonA G Stewart
Jun 2, 1995·The Journal of Biological Chemistry·W H Moolenaar
Jun 1, 1994·Scandinavian Journal of Urology and Nephrology·J R Andersen, J K Kristensen
Mar 1, 1996·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·J P Hieble, R R Ruffolo
Nov 1, 1996·The Journal of Cell Biology·J H HechtJ Chun
Nov 1, 1996·British Journal of Pharmacology·K NasuJ Yano
Mar 4, 1997·Circulation·S M YuC C Lin
Apr 1, 1997·Current Opinion in Cell Biology·W H MoolenaarG C Zondag
Jun 23, 1997·FEBS Letters·F GaitsH Chap
Mar 6, 1998·Medical Hypotheses·W G Roper
Apr 4, 1998·Molecular Pharmacology·J H GuhC M Teng
May 9, 1998·The Journal of Biological Chemistry·S AnE J Goetzl
May 16, 1998·Current Biology : CB·M C van DijkW H Moolenaar
Jun 27, 1998·Biochemical and Biophysical Research Communications·P StaceyS C Phillips
Sep 5, 1998·JAMA : the Journal of the American Medical Association·Y XuG Casey
Nov 6, 1998·Molecular Pharmacology·S AnE J Goetzl
Nov 25, 1998·Journal of Molecular Neuroscience : MN·U K NilssonS P Svensson
May 20, 1999·The Journal of Urology·J K ChonN Kyprianou
May 27, 1999·The Prostate·S T BoeschH Klocker
Jun 24, 1999·Thrombosis Research·I GenneroP Sié
Jul 1, 1999·Molecular Pharmacology·I V TurkoJ D Corbin
Jul 15, 1999·International Journal of Urology : Official Journal of the Japanese Urological Association·T GotoK Takeda
Sep 17, 1999·The Journal of Biological Chemistry·K BandohK Inoue
Dec 2, 1999·Experimental Cell Research·W H Moolenaar
Jan 5, 2000·Seminars in Surgical Oncology·L J Denis, K Griffiths
Feb 25, 2000·The Journal of Urology·C GuoD T Price
Aug 24, 2000·Molecular Human Reproduction·P I AdolfssonS P Svensson
Citations
Feb 13, 2009·Der Urologe. Ausg. A·K Höfner, M Oelke
Jul 9, 2008·World Journal of Urology·George T KediaMartin Burchardt
Jul 24, 2008·International Urology and Nephrology·Esref O GuvenEge C Serefoglu
Aug 22, 2009·La Radiologia medica·M BertolottoM A Cova
Sep 4, 2008·Current Urology Reports·Hartmut PorstErnst Ulbrich
Mar 11, 2004·Veterinary Immunology and Immunopathology·K J RickardsF M Cunningham
Nov 26, 2003·Cellular Signalling·Anna-Louise M Cook, John M Haynes
Feb 28, 2008·Nature Clinical Practice. Urology·Anand K Patel, Christopher R Chapple
Aug 19, 2009·Prostate Cancer and Prostatic Diseases·S Mouli, K T McVary
Oct 27, 2011·American Journal of Physiology. Endocrinology and Metabolism·Xinhua ZhangMichael E Disanto
Feb 28, 2004·Endocrinology·Shinji SakamotoYoshiyuki Kakehi
Sep 23, 2014·Tissue & Cell·Fabiana Oliveira dos Santos GomesChristina Alves Peixoto
Nov 6, 2009·Current Opinion in Urology·Chunyu Wang
Jun 24, 2008·Expert Opinion on Pharmacotherapy·Konstantinos GiannitsasPetros Perimenis
Feb 14, 2007·The Journal of Urology·Kevin T McVaryGene van den Ende
Nov 26, 2008·The Prostate·Yu ZengXiu-Xian Wu
Jul 20, 2007·The Prostate·Chi-Ming LiuIng-Jun Chen
Sep 8, 2006·BJU International·Hanna TinelPeter Sandner
Mar 18, 2011·British Journal of Pharmacology·S VenturaB Exintaris
Jul 11, 2003·The Journal of Urology·Kazem M AzadzoiMike B Siroky
Jul 17, 2004·Regulatory Peptides·Jing-Hui YangChao-Shu Tang
Sep 18, 2015·Journal of Inflammation·Christina Alves Peixoto, Fabiana Oliveira Dos Santos Gomes
Mar 4, 2015·Urology·Per I AdolfssonSamuel P S Svensson
Oct 30, 2016·Neurourology and Urodynamics·Abdulkadir GumrahTufan Tarcan
Jul 11, 2014·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Seyed Hossein Hosseini SharifiMohammad Hossein Soltani
Oct 2, 2015·Therapeutic Advances in Urology·Osamu YokoyamaLars Viktrup
Jul 27, 2005·BJU International·André ReitzBrigitte Schurch
Mar 23, 2019·Expert Opinion on Pharmacotherapy·Fabiola Zakia Mónica, Gilberto De Nucci
Jun 10, 2018·The Journal of Pharmacology and Experimental Therapeutics·Kazuyuki SakamotoNoriyuki Masuda
Aug 14, 2019·Lower Urinary Tract Symptoms·Tomohiro MatsuoHideki Sakai